rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-2-17
|
pubmed:abstractText |
Metronomic chemotherapy has shown efficacy in patients with metastatic breast cancer. Pegylated liposomal-doxorubicin (PLD) pharmacokinetic characteristics support the rationale for using the drug in a metronomic fashion, potentially able to combine anthracyclines efficacy to a low toxicity profile.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1532-3080
|
pubmed:author |
pubmed-author:AdamoliLL,
pubmed-author:Cossu RoccaMM,
pubmed-author:CuriglianoGG,
pubmed-author:Di PietroAA,
pubmed-author:GoldhirschAA,
pubmed-author:MarenghiCC,
pubmed-author:MinchellaII,
pubmed-author:MunzoneEE,
pubmed-author:NolèFF,
pubmed-author:RadiceDD,
pubmed-author:VerriEE
|
pubmed:copyrightInfo |
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33-7
|
pubmed:meshHeading |
pubmed-meshheading:19884008-Adult,
pubmed-meshheading:19884008-Antibiotics, Antineoplastic,
pubmed-meshheading:19884008-Breast Neoplasms,
pubmed-meshheading:19884008-Chemotherapy, Adjuvant,
pubmed-meshheading:19884008-Dose-Response Relationship, Drug,
pubmed-meshheading:19884008-Doxorubicin,
pubmed-meshheading:19884008-Drug Administration Schedule,
pubmed-meshheading:19884008-Female,
pubmed-meshheading:19884008-Humans,
pubmed-meshheading:19884008-Middle Aged,
pubmed-meshheading:19884008-Neoplasm Metastasis,
pubmed-meshheading:19884008-Pilot Projects,
pubmed-meshheading:19884008-Polyethylene Glycols,
pubmed-meshheading:19884008-Quality of Life,
pubmed-meshheading:19884008-Time Factors,
pubmed-meshheading:19884008-Women's Health
|
pubmed:year |
2010
|
pubmed:articleTitle |
Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: a mono-institutional case-series report.
|
pubmed:affiliation |
Division of Medical Oncology, European Institute of Oncology, via Ripamonti 435, Milan, Italy. elisabetta.munzone@ieo.it
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|